Roxas, Siegreed Rey D.

HRN: 26-44-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2025
CEFOTAXIME 500MG (VIAL)
01/02/2025
01/09/2025
IV
170
Q12
PSNB
Waiting Final Action 
01/02/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/02/2025
01/09/2025
IV
51mg
Q24
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: